How Can Specialty Pharmacies Support Adherence as Copays Rise?

Video

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses methods to overcome the challenge of high out-of-pocket costs that can have a negative impact on patient medication adherence.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses methods to overcome the challenge of high out-of-pocket costs that can have a negative impact on patient medication adherence.

Related Videos
Male pharmacist in white coat with stethoscope and clipboard over drugstore background | Image Credit: Syda Productions - stock.adobe.com
Medical professional researching on a laptop while taking notes
Credit: Adobe Stock - Tierney
https://www.youtube.com/watch?v=Q-WCvWaAcC8
Yaruniv-Studio - stock.adobe.com
Related Content

FDA Approves Nedosiran for Patients With Primary Hyperoxaluria Type 1

October 2nd 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Bridging the Gap: Industry-Academia Collaboration in Pharmacy

September 29th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

Researchers Create Hydrogel That Could Improve HIV Therapy Compared to Current Treatments

September 27th 2023

Encephalitis Can Change How the World Thinks About Complex Neuropsychiatric Disorders

September 26th 2023

FDA Approves Nedosiran for Patients With Primary Hyperoxaluria Type 1

October 2nd 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Bridging the Gap: Industry-Academia Collaboration in Pharmacy

September 29th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

Researchers Create Hydrogel That Could Improve HIV Therapy Compared to Current Treatments

September 27th 2023

Encephalitis Can Change How the World Thinks About Complex Neuropsychiatric Disorders

September 26th 2023

FDA Approves Nedosiran for Patients With Primary Hyperoxaluria Type 1

October 2nd 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Bridging the Gap: Industry-Academia Collaboration in Pharmacy

September 29th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

Researchers Create Hydrogel That Could Improve HIV Therapy Compared to Current Treatments

September 27th 2023

Encephalitis Can Change How the World Thinks About Complex Neuropsychiatric Disorders

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.